JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-5922
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study ; day:17 ; month:2 ; year:2020 ; pages:1-13
Journal of gastroenterology ; (17.2.2020), 1-13
- Urheber
-
Takehara, Tetsuo
Chayama, Kazuaki
Kurosaki, Masayuki
Yatsuhashi, Hiroshi
Tanaka, Yasuhito
Hiramatsu, Naoki
Sakamoto, Naoya
Asahina, Yasuhiro
Nozaki, Akito
Nakano, Toshikazu
Hagiwara, Yosuke
Shimizu, Hiroko
Yoshida, Hiroki
Huang, Yuhan
Biermer, Michael
Vijgen, Leen
Hayashi, Norio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00535-020-01672-0
- URN
-
urn:nbn:de:101:1-2020051323352533197030
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takehara, Tetsuo
- Chayama, Kazuaki
- Kurosaki, Masayuki
- Yatsuhashi, Hiroshi
- Tanaka, Yasuhito
- Hiramatsu, Naoki
- Sakamoto, Naoya
- Asahina, Yasuhiro
- Nozaki, Akito
- Nakano, Toshikazu
- Hagiwara, Yosuke
- Shimizu, Hiroko
- Yoshida, Hiroki
- Huang, Yuhan
- Biermer, Michael
- Vijgen, Leen
- Hayashi, Norio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the telaprevir early access program in patients from Romania
Comparison of anti-HBV regimen with or without adefovir on hepatocellular carcinoma development of Chronic hepatitis B patients with compensated cirrhosis: a retrospective cohort study
Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
Berlin 4178 (Ms. or. quart 115). Fol. 536b-537a.
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure
Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study
Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
4178
Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
Living donor liver transplantation indicated for compensated liver cirrhosis with symptomatic gallstone diseases: report of two cases
Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the telaprevir early access program in patients from Romania
Comparison of anti-HBV regimen with or without adefovir on hepatocellular carcinoma development of Chronic hepatitis B patients with compensated cirrhosis: a retrospective cohort study
Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
Berlin 4178 (Ms. or. quart 115). Fol. 536b-537a.
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure
Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study
Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
4178
Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
Living donor liver transplantation indicated for compensated liver cirrhosis with symptomatic gallstone diseases: report of two cases
Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
Treatment of hepatitis C genotype 1 patients with severe fibrosis or compensated cirrhosis: the telaprevir early access program in patients from Romania
Comparison of anti-HBV regimen with or without adefovir on hepatocellular carcinoma development of Chronic hepatitis B patients with compensated cirrhosis: a retrospective cohort study
Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
Berlin 4178 (Ms. or. quart 115). Fol. 536b-537a.
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure
Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study
Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
4178
Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis